Preclinical antiarthritic activity of matrix metalloproteinase inhibitors.

Ann N Y Acad Sci

SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-0939.

Published: September 1994

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.1994.tb24769.xDOI Listing

Publication Analysis

Top Keywords

preclinical antiarthritic
4
antiarthritic activity
4
activity matrix
4
matrix metalloproteinase
4
metalloproteinase inhibitors
4
preclinical
1
activity
1
matrix
1
metalloproteinase
1
inhibitors
1

Similar Publications

Introduction: Osteoarthritis (OA) is a degenerative joint disease that can affect the many tissues of the joint. There are no officially recognized disease-modifying therapies for clinical use at this time probably due to a lack of complete comprehension of the pathogenesis of the disease. In recent years, emerging regenerative therapy and treatments with stem cells both undifferentiated and differentiated cells have gained much attention as they can efficiently promote tissue repair and regeneration.

View Article and Find Full Text PDF
Article Synopsis
  • Rheumatoid Arthritis (RA) is a chronic autoimmune disease mainly affecting individuals aged 30-50, characterized by symptoms like morning stiffness, joint pain, and fatigue.
  • Various risk factors for RA include hormonal, genetic, and environmental influences, as well as lifestyle choices like smoking and diet.
  • The review emphasizes the therapeutic potential of 17 native plant species with anti-arthritic properties, while also highlighting the need for more thorough research to confirm their efficacy and safety for RA treatment.
View Article and Find Full Text PDF

Osteoarthritis (OA) is a degenerative disease that affects the quality of life in elderly and young populations. Current therapies using corticosteroids and non-steroidal anti-inflammatory drugs via parenteral or oral routes show limited ability to retard progression of the disease and achieve long term effectiveness and safety. Herein, the potential of MT-Cur combinatorial nano-formulations in OA management was explored for the first time.

View Article and Find Full Text PDF

The immunomodulatory enzyme IDO2 is an essential mediator of autoantibody production and joint inflammation in preclinical models of autoimmune arthritis. Although originally identified as a tryptophan-catabolizing enzyme, we recently discovered a previously unknown nonenzymatic pathway is essential for the proarthritic function of IDO2. We subsequently identified Runx1 (Runt-related transcription factor 1) as a potential component of the nonenzymatic pathway IDO2 uses to drive arthritis.

View Article and Find Full Text PDF
Article Synopsis
  • Fumaric acid is a special substance found in fruits and vegetables that may help reduce inflammation and arthritis symptoms in rats.
  • In the study, rats with arthritis were given fumaric acid and it helped lessen swelling and improve health markers in their bodies.
  • The results showed that fumaric acid worked well, especially when combined with another medicine called methotrexate, but more research is needed before it can be used as a treatment for humans.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!